Stock Events

Stock Events

Aktis Oncology (AKTS) Q2 2024 Earnings

13MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.26

-0.21

-0.17

-0.12

Details

Expected EPS

-0.12

Actual EPS

-0.14

Surprise EPS

-0.02

Surprise Percent

+16.67%

Description

Aktis Oncology (AKTS) has reported earnings of -0.14 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.